Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results

PURPOSE: To evaluate frequency of injections, visual and anatomical outcomes of neovascular age-related macular degeneration (nAMD) patients transitioned to intravitreal aflibercept after failure to extend treatment interval beyond 8 weeks with prior intravitreal bevacizumab or ranibizumab. METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eye (Lond)
Hlavní autoři: Homer, N, Grewal, D S, Mirza, R G, Lyon, A T, Gill, M K
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2015
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565952/
https://ncbi.nlm.nih.gov/pubmed/26021870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.87
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky